N/A
N=40
Assessing and Improving Patient Knowledge About Keloid Scars (Keloids)
Keloid Scar
Bottom Line
View on ClinicalTrials.gov: NCT01176877 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jan 2013
Primary outcome: Primary: To Assess the Impact of an Educational Lecture on Knowledge About Keloid Scars by Comparing Mean Scores Between Knowledge Assessment Questionnaires Administered Before an Educational Lecture and Immediately After an Educational Lecture — 12.9; 18.3 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Scripted lecture ("educational information talk") (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- Sep 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY To Assess the Impact of an Educational Lecture on Knowledge About Keloid Scars by Comparing Mean Scores Between Knowledge Assessment Questionnaires Administered Before an Educational Lecture and Immediately After an Educational Lecture |
12.9; 18.3 | — |
| SECONDARY To Assess the Impact of an Educational Lecture on Long-term Knowledge Retention About Keloid Scars by Comparing Mean Scores Between Knowledge Assessment Questionnaires Administered Before an Educational Lecture and 3 Months After an Educational Lecture |
13.2; 16.8 | — |
Summary
The purpose of this study is:
* to identify how knowledge about keloid scars and self-treatments differs between patients who use the Internet as a source of information and patients who do not
* to determine if patients who are at a high risk of developing additional keloid scars are more or less likely to change their behavior based on an educational information talk about keloid scar prevention
Eligibility Criteria
Inclusion Criteria
- Subjects with a clinical diagnosis of keloid scarring
- Subjects over the age of 18
Exclusion Criteria
- That which does not fit the inclusion criteria
Data sourced from ClinicalTrials.gov (NCT01176877). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.